579-93-1,MFCD00444173
Catalog No.:AA00EFSX

579-93-1 | 2-(Benzoylamino)benzoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$43.00   $30.00
- +
5g
98%
in stock  
$113.00   $79.00
- +
10g
98%
in stock  
$172.00   $120.00
- +
25g
98%
in stock  
$332.00 $233.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00EFSX
Chemical Name:
2-(Benzoylamino)benzoic acid
CAS Number:
579-93-1
Molecular Formula:
C14H11NO3
Molecular Weight:
241.2420
MDL Number:
MFCD00444173
SMILES:
O=C(c1ccccc1)Nc1ccccc1C(=O)O
UNII:
6085493379
NSC Number:
3866
FEMA Number:
4078
Properties
Computed Properties
 
Complexity:
310  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.5  

Literature

Title: N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.

Journal: Bioorganic & medicinal chemistry letters 20120915

Title: Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation.

Journal: Organic & biomolecular chemistry 20111021

Title: Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

Journal: ChemMedChem 20101203

Title: DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.

Journal: Biochemical pharmacology 20091015

Title: Disubstituted 4(3H) quinazolones: a novel class of antitumor agents.

Journal: Chemical biology & drug design 20090901

Title: In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.

Journal: ChemMedChem 20090301

Title: Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.

Journal: Bioorganic & medicinal chemistry 20080515

Title: QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.

Journal: European journal of medicinal chemistry 20080501

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.

Journal: Bioorganic & medicinal chemistry letters 20051201

Title: Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.

Journal: Journal of medicinal chemistry 20050310

Title: NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.

Journal: Journal of medicinal chemistry 20040923

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:579-93-1 Molecular Formula|579-93-1 MDL|579-93-1 SMILES|579-93-1 2-(Benzoylamino)benzoic acid
Catalog No.: AA00EFSX
579-93-1,MFCD00444173
579-93-1 | 2-(Benzoylamino)benzoic acid
Pack Size: 1g
Purity: 98%
in stock
$43.00 $30.00
Pack Size: 5g
Purity: 98%
in stock
$113.00 $79.00
Pack Size: 10g
Purity: 98%
in stock
$172.00 $120.00
Pack Size: 25g
Purity: 98%
in stock
$332.00 $233.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00EFSX
Chemical Name: 2-(Benzoylamino)benzoic acid
CAS Number: 579-93-1
Molecular Formula: C14H11NO3
Molecular Weight: 241.2420
MDL Number: MFCD00444173
SMILES: O=C(c1ccccc1)Nc1ccccc1C(=O)O
UNII: 6085493379
NSC Number: 3866
FEMA Number: 4078
Properties
Complexity: 310  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.5  
Literature fold

Title: N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.

Journal: Bioorganic & medicinal chemistry letters20120915

Title: Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation.

Journal: Organic & biomolecular chemistry20111021

Title: Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

Journal: ChemMedChem20101203

Title: DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.

Journal: Biochemical pharmacology20091015

Title: Disubstituted 4(3H) quinazolones: a novel class of antitumor agents.

Journal: Chemical biology & drug design20090901

Title: In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.

Journal: ChemMedChem20090301

Title: Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.

Journal: Bioorganic & medicinal chemistry20080515

Title: QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.

Journal: European journal of medicinal chemistry20080501

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.

Journal: Bioorganic & medicinal chemistry letters20051201

Title: Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.

Journal: Journal of medicinal chemistry20050310

Title: NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.

Journal: Journal of medicinal chemistry20040923

Building Blocks More >
5694-68-8
5694-68-8
2-Hydroxymethyl-1,3-dioxolane
AA00EG7F | MFCD08062572
5766-67-6
5766-67-6
(ETHYLENEDINITRILO)TETRAACETONITRILE
AA00EGOO | MFCD00019818
618382-78-8
618382-78-8
3-(Thiophen-2-yl)-1-p-tolyl-1h-pyrazole-5-carboxylic acid
AA00EI4V | MFCD05150660
590-37-4
590-37-4
2-Methylpent-4-yn-2-ol
AA00EIC4 | MFCD13192001
56984-55-5
56984-55-5
4-methyl-6-phenyl-1,6-dihydropyrazolo[3,4-c]pyrazol-3-amine
AA00EIRI | MFCD09041223
603122-79-8
603122-79-8
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid, pinacol ester
AA00EJ2H | MFCD11855962
5933-29-9
5933-29-9
BENZOTRIAZOLE-1-CARBOXAMIDE
AA00EJ97 | MFCD00962944
62484-12-2
62484-12-2
7-Methoxyquinazoline-2,4-diol
AA00EJRC | MFCD09954839
58791-79-0
58791-79-0
5-Amino-1-(2,4-dichlorophenyl)-1H-pyrazole-4-carbonitrile
AA00EK07 | MFCD00067795
58076-32-7
58076-32-7
4-Propoxybenzene-1-sulfonyl chloride
AA00EKDU | MFCD09809340
Submit
© 2017 AA BLOCKS, INC. All rights reserved.